Acetaminophen structure-toxicity studies: in vivo covalent binding of a nonhepatotoxic analog, 3-hydroxyacetanilide.
High doses of 3-hydroxyacetanilide (3HAA), a structural isomer of acetaminophen, do not produce hepatocellular necrosis in normal male hamsters or in those sensitized to acetaminophen-induced liver damage by pretreatment with a combination of 3-methylcholanthrene, borneol, and diethyl maleate. Although 3HAA was not hepatotoxic, the administration of acetyl-labeled [3H or 14C]3HAA (400 mg/kg, ip) produced levels of covalently bound radiolabel that were similar to those observed after an equimolar, hepatotoxic dose of [G-3H]acetaminophen. The covalent nature of 3HAA binding was demonstrated by retention of the binding after repetitive organic solvent extraction following protease digestion. Hepatic and renal covalent binding after 3HAA was approximately linear with both dose and time. In addition, 3HAA produced only a modest depletion of hepatic glutathione, suggesting the lack of a glutathione threshold. 3-Methylcholanthrene pretreatment increased and pretreatment with cobalt chloride and piperonyl butoxide decreased the hepatic covalent binding of 3HAA, indicating the involvement of cytochrome P450 in the formation of the 3HAA reactive metabolite. The administration of multiple doses or a single dose of [ring-3H]3HAA to hamsters pretreated with a combination of 3-methylcholanthrene, borneol, and diethyl maleate produced hepatic levels of 3HAA covalent binding that were in excess of those observed after a single, hepatotoxic acetaminophen dose. These data suggest that the nature and/or the intracellular processing of the reactive metabolites of acetaminophen and 3HAA are different. These data also demonstrate that absolute levels of covalently bound xenobiotic metabolites cannot be utilized as absolute predictors of cytotoxic potential.
Roberts
S A
SA
Department of Pharmacology, Medical University of South Carolina, Charleston 29425.
Price
V F
VF
Jollow
D J
DJ
D000082:Acetaminophen / Q000378:metabolism* / Q000633:toxicity; D000083:Acetanilides / Q000378:metabolism* / Q000633:toxicity; D000700:Analgesics / Q000378:metabolism*; D000818:Animals; D001665:Binding Sites; D002250:Carbon Radioisotopes; D006224:Cricetinae; D005978:Glutathione / Q000378:metabolism; D007668:Kidney / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D007700:Kinetics; D008099:Liver / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D008297:Male; D008647:Mesocricetus; D009132:Muscles / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D009928:Organ Specificity; D013329:Structure-Activity Relationship; D014316:Tritium
D000083:Acetanilides; D000700:Analgesics; D002250:Carbon Radioisotopes; D014316:Tritium; D000082:Acetaminophen; C026137:3-hydroxyacetanilide; D005978:Glutathione